1-7 of 7 results for subject:MRSA
Librarians' tools
- Search time
- 0.204 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:MRSA
- We searched for
- subject_t:MRSA OR subject_t:"Methicillin resistant staphylococcus aureus" OR subject_ses:11632
Year
X
2010
Type
House
Session
Month
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health how many (a) deaths from and (b) cases of (i) clostridium difficile and (ii) MRSA there have been in each region in each of the last three years.
To ask the Secretary of State for Health how many (a) deaths from and (b) cases of (i) clostridium difficile and (ii) MRSA there have been in each region in each of the last three years.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Nick Hurd
(Conservative)
Answering body
United Kingdom Statistics Authority
Type
Written questions
Status
Answered
Tabled on
22 November 2010
For answer on
24 November 2010
Answered on
2 December 2010
I have been asked to reply.The information requested falls within the responsibility of the UK Statistics Authority. I have asked the authority to reply.Letter from Stephen Penneck, dated November 2010:"As Director General for the Office for National Statistics, I have been asked to reply to your recent question asking how many (a) deaths from and (b) cases of (i) Clostridium difficile and (ii) MRSA there have been in each region in each of the last three years. (26595)""Table 1 attached provides (a) the number of deaths where (i) Clostridium difficile (C. difficile) and (ii) methicillin-resistant Staphylococcus aureus (MRSA) was mentioned anywhere on the death certificate, either as the underlying cause or as a contributory factor, in each government office region in England, for the years 2007 to 2009 (the latest year available).""It should be noted that these figures include all deaths where C. difficile or MRSA was mentioned on the death certificate, either as an underlying cause or contributory factor. Those who die with ""C. difficile or MRSA are usually patients who are already very ill, and it is their existing illness which is often designated as the underlying cause of death.""The number of deaths involving MRSA and C. difficile registered in England and Wales each year by sex and age are published annually on the National Statistics website:""MRSA:""www.statistics.gov.uk/StatBase/Product.asp?vlnk=13571""C. difficile:""www.statistics.gov.uk/statbase/Product.asp?vlnk=14782""Figures for C. difficile and MRSA infections are published by the Health Protection Agency (HPA). Table 2 attached provides (b) the number of (i) C. difficile infections in people aged 2 years and over and (ii) MRSA bloodstream infections in acute NHS trusts by government office region in England for the last three financial years 2007/08 to 2009/10 (the latest year available).""The HPA publishes regular reports about antimicrobial surveillance, healthcare associated infections and their consequences for human health in the UK, these are available on the HPA website:""www.hpa.org.uk/Publications/InfectiousDiseases/AntimicrobialAndHealthcareAssociatedInfections/"
| Table 1. Number of deaths where methicillin-resistant Staphylococcus aureus (MRSA)¹ and Clostridium difficile (C. difficile)² was mentioned on the death certificate, government office regions in England, 2007-09³,4 | ||||||
|---|---|---|---|---|---|---|
| Deaths (persons) | ||||||
| MRSA | C. difficile | |||||
| Government office region | 2007 | 2008 | 2009 | 2007 | 2008 | 2009 |
| North East | 85 | 88 | 53 | 328 | 347 | 311 |
| North West | 199 | 171 | 99 | 1,010 | 980 | 733 |
| Yorkshire and The Humber | 130 | 105 | 68 | 510 | 486 | 298 |
| East Midlands | 116 | 98 | 65 | 823 | 502 | 339 |
| West Midlands | 202 | 147 | 69 | 1,255 | 771 | 440 |
| East of England | 192 | 105 | 68 | 1,035 | 465 | 330 |
| London | 174 | 133 | 98 | 1,001 | 534 | 289 |
| South East | 224 | 167 | 118 | 1,080 | 750 | 481 |
| South West | 195 | 123 | 80 | 874 | 630 | 329 |
| ¹ Identified using the methodology described in Office for National Statistics: Statistical Bulletin: Deaths involving MRSA: England and Wales, 2009. Available at: | ||||||
| www.statistics.gov.uk/pdfdir/mrsa0810.pdf | ||||||
| ² Identified using the methodology described in Office for National Statistics: Statistical Bulletin: Deaths involving Clostridium difficile: England and Wales, 2009. Available at: | ||||||
| www.statistics.gov.uk/pdfdir/cdif0810.pdf | ||||||
| ³ Based on boundaries as of 2010. | ||||||
| 4 Figures are for deaths registered in each calendar year. |
| Table 2. Number of methicillin-resistant Staphylococcus aureus (MRSA)¹ bloodstream infections and Clostridium difficile (C. difficile)² infections in acute NHS trusts by government office region in England, 2007-09³,4 | ||||||
|---|---|---|---|---|---|---|
| Infections | ||||||
| MRSA | C. difficile | |||||
| Government office region | 2007 | 2008 | 2009 | 2007 | 2008 | 2009 |
| North East | 302 | 188 | 84 | 3,379 | 2,706 | 1,873 |
| North West | 670 | 419 | 303 | 9,574 | 6,722 | 4,909 |
| Yorkshire and The Humber | 519 | 356 | 226 | 5,156 | 4,091 | 2,463 |
| East Midlands | 254 | 187 | 138 | 3,691 | 2,475 | 1,957 |
| West Midlands | 511 | 307 | 161 | 7,071 | 4,088 | 3,065 |
| East of England | 333 | 213 | 146 | 5,573 | 2,818 | 2,265 |
| London | 823 | 579 | 409 | 7,270 | 4,326 | 3,011 |
| South East | 586 | 395 | 257 | 7,616 | 5,003 | 3,538 |
| South West | 453 | 291 | 174 | 6,168 | 3,866 | 2,523 |
| ¹ Figures for the number of infections are provided by the Health Protection Agency (HPA). Infections are identified using the methodology described in the HPA report: Healthcare-Associated Infections and Antimicrobial Resistance: 2009/10. Available at: | ||||||
| www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1281954479045 | ||||||
| ² The number of Clostridium difficile infections is given for people aged two years and over. | ||||||
| ³ Based on HPA regions which are equivalent to Government office regions. | ||||||
| 4 Figures are for infections in each financial year. |
Subjects
Death; MRSA; Clostridium
Date
2 December 2010
Reference
26595; 519 c1008-10W
House
House of Commons
To ask the Secretary of State for Health what steps his Department is taking to reduce the incidence of MRSA.
To ask the Secretary of State for Health what steps his Department is taking to reduce the incidence of MRSA.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
22 November 2010
For answer on
24 November 2010
Answered on
1 December 2010
This Government are determined to do all they can to support the health and adult social care providers reduce Methicillin-resistant Staphylococcus aureus (MRSA). From the outset, through the Coalition Agreement, this Government made clear that they expected the national health service to adopt a zero tolerance approach to all health care associated infections (HCAIs), including MRSA.In the revision of the 2010-11 Operating Framework published in June, it was made clear that the NHS should continue prioritising the achievement of the MRSA objective. The successful implementation of this objective will deliver both an overall reduction nationally and, importantly, will reduce variation by moving all organisations towards the performance of the best.At the same time, the revision of the Operating Framework confirmed that it expected and required the NHS to implement MRSA screening of all relevant emergency admissions by the end of this year.[n terms of using the availability of data as a driver to supporting further reductions in MRSA, we have introduced weekly data publication of both MRSA blood stream infections and Clostridium difficile infections at hospital site level.We are also committed to ensuring that the NHS continue to have access to evidence based guidance in order that they can reduce the number of all HCAIs, including MRSA, through the implementation of effective infection prevention and control practices. This guidance is available on the Department of Health's ““Clean, Safe Care”” website.The Health and Social Care Act 2008 ““Code of Practice for health and adult social care on the Prevention and Control of Infections and related guidance””, which the Care Quality Commission use as a basis for assessing compliance with the registration requirement on cleanliness and infection control has been a driver for improvement in the hospital setting. The scope of the Code has already been extended to adult social care settings and will include primary care in due course so that we can ensure that all settings where patients receive care and treatment operate comparable infection prevention and control practices.
Subjects
MRSA; Screening
Date
1 December 2010
Reference
26392; 519 c899-900W
House
House of Commons
To ask the Secretary of State for Health what progress has been made towards meeting his Department's 2011 deadline for the screening of non-elective patients for MRSA.
To ask the Secretary of State for Health what progress has been made towards meeting his Department's 2011 deadline for the screening of non-elective patients for MRSA.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
22 November 2010
For answer on
24 November 2010
Answered on
1 December 2010
As outlined in the ““NHS Operating Framework 2010/11””, there is a requirement to introduce Methicillin-resistant Staphylococcus aureus screening. Good progress is being made by organisations to implement screening for this cohort of patients, with some organisations already having declared full implementation of the policy and all organisations planning to implement emergency screening for relevant emergency admissions within the expected time scale. Strategic health authorities will continue to monitor delivery towards the requirement by 31 December 2010.
Subjects
MRSA; Screening
Date
1 December 2010
Reference
26390; 519 c899W
House
House of Commons
To ask the Secretary of State for Health what information his Department collates for the purpose of monitoring rates of MRSA.
To ask the Secretary of State for Health what information his Department collates for the purpose of monitoring rates of MRSA.
Asked by
Lord Watson of Wyre Forest
(Labour)
Answered by
Simon Burns
(Conservative)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
22 November 2010
For answer on
24 November 2010
Answered on
1 December 2010
Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia are subject to mandatory reporting to the Health Protection Agency. The Department uses the outputs from this system to assess and monitor rates of MRSA bacteraemia at both national and local levels.
Subjects
MRSA; Screening
Date
1 December 2010
Reference
26391; 519 c900W
House
House of Commons
Type
Select Committee reports (Government responses);
Command papers
Author
Treasury
Laid on
27 January 2010
Subjects
Databases; Cost effectiveness; Closures; Construction; Capital investment; Hospitals; Health services; ICT; Disease control; Hygiene; Infectious diseases; Offenders; NHS; Personal records; Prisoners; Prisons; Management; Post offices; Post Office; Probation; MRSA; Standards; Repairs and maintenance; Treasury; Reorganisation; Cleaning services; Committee of Public Accounts; Clostridium; Prison accommodation; National offender management information system; Bard
Date
27 January 2010
Reference
Cm 7793
House
House of Commons
To ask the Secretary of State for Health what tests are available to detect (a) MRSA and (b) clostridium difficile infection; and by what means such tests are deployed in the NHS.
To ask the Secretary of State for Health what tests are available to detect (a) MRSA and (b) clostridium difficile infection; and by what means such tests are deployed in the NHS.
Asked by
Lynne Jones
(Labour)
Answered by
Ann Keen
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
5 January 2010
For answer on
7 January 2010
Answered on
12 January 2010
Diagnostic tests for the presence and illness caused by both Methicillin Resistant Staphylococcus Aureus and Clostridium difficile can be divided into the following categories:"simple methods using routine culture that rely on the initial growth of the organism from a clinical specimen and may take 24 to 72 hours to produce a result;""rapid tests that may detect parts of these bacteria, such as toxins, enzymes or nucleic acids such as DNA or RNA (molecular tests) and may produce results in hours; and""combinations of these methods designed to improve performance and minimise cost."The actual choice of test or combination of tests is a decision made by each laboratory. This decision is based on experience and national guidance, for example diagnostic methods published by the Health Protection Agency.
Subjects
Hospitals; Infectious diseases; MRSA; Clostridium
Date
12 January 2010
Reference
503 c913W; 309967
House
House of Commons
To ask the Secretary of State for Health what recent progress has been made on the deployment in the NHS of new tests for (a) MRSA and (b) clostridium difficile; and what steps he is taking to ensure the deployment in the NHS of the most accurate, rapid and cost-effective...
To ask the Secretary of State for Health what recent progress has been made on the deployment in the NHS of new tests for (a) MRSA and (b) clostridium difficile; and what steps he is taking to ensure the deployment in the NHS of the most accurate, rapid and cost-effective...
Asked by
Lynne Jones
(Labour)
Answered by
Ann Keen
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
5 January 2010
For answer on
7 January 2010
Answered on
12 January 2010
Information on the tests used by National Health Service laboratories is not collected centrally.We provide advice and guidance to help laboratories develop testing strategies and measures taken include for:Methicillin Resistant Staphylococcus Aureus (MRSA)"The Department has held productive discussions with the manufacturers of these testing kits and has funded research on the practical implementation of rapid molecular technology in two clinical centres.""Guidance on testing for MRSA screening."Clostridium difficile (C. difficile ) infection"Advice was issued by the Department of Health and the Health Protection Agency (HPA) on testing strategies in March 2009, following the publication of the Centre for Evidence Based Purchasing report on the performance of C. difficile test kits. The Department and HPA are currently undertaking further work to refine this guidance.""The Department has also initiated discussions with manufacturers on how they can improve the accuracy and specificity of their C. difficile testing kits."
Subjects
Hospitals; Infectious diseases; MRSA; Clostridium
Date
12 January 2010
Reference
503 c913W; 309968
House
House of Commons